Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer.

Osamu Ishizuka,Osamu Nishizawa,Shuji Nishizawa,Tomoya Satoh,Masahisa Wajiki,Hideo Kiyokawa,Yoshihiro Inoue,Shinya Kobayashi,Hiroya Mizusawa,Tatsuo Nakagawa

Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer.

2013

Osamu Ishizuka
Osamu Nishizawa
Shuji Nishizawa
Tomoya Satoh
Masahisa Wajiki
Hideo Kiyokawa
Yoshihiro Inoue
Shinya Kobayashi
Hiroya Mizusawa
Tatsuo Nakagawa

Background We compared the efficacy and safety of 1- and 3-month depots of the luteinizing hormone-releasing hormone (LH-RH) agonist goserelin acetate in prostate cancer patients.

Keywords:

Luteinizing hormone-releasing hormone agonist
Hormone
Goserelin Acetate
Prostate cancer
Agonist
Androgen deprivation therapy
Internal medicine
Endocrinology
Medicine
Pathology
Oncology
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations